BMBL vs HNGE: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: BMBL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BMBL and HNGE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BMBL and HNGE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Bumble Inc. operates online dating and social-connection apps, anchored by its flagship Bumble app, where women make the first move, and the older Badoo brand that is strong in Europe and Latin America. The company earns revenue mainly through paid subscriptions and a la carte features such as boosts and premium visibility, so results track paying users and average revenue per paying user rather than advertising. Founder Whitney Wolfe Herd returned as CEO and has pushed a strategic reset focused on trust, member quality, and real-world dates rather than raw scale.

Full BMBL guide

Hinge Health is a digital musculoskeletal (MSK) care platform that provides physical therapy, pain management, and surgery prevention services through a combination of software, connected sensor hardware, and human care teams. The company's core offering combines a mobile and connected-sensor app with personalized exercise therapy programs, behavioral health support, and access to physical therapists, plus care navigation for surgery decisions. Customers are primarily large employers and health plans that purchase Hinge Health benefits for their members.

Full HNGE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BMBL drivers: The Bumble 2.0 AI relaunch; Profitability and cost discipline.
• HNGE drivers: Employer benefit penetration; Surgery prevention as ROI driver.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central risk is that the deliberate reset never reverses into growth: paying users and revenue are both falling, and a smaller base can keep shrinking if the AI relaunch does not reignite demand. For HNGE, digital health categories are competitive with various platforms targeting MSK and other condition areas.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BMBL if you believe its drivers more; HNGE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BMBL and HNGE guides.

BMBL. Figures are approximate, tied to the asOf date, and drawn from the most recent reported quarter, so verify live numbers before acting. Bumble is mid-transition: revenue and paying users are declining by design while profitability improves, which makes point-in-time multiples less meaningful than the trajectory of the Bumble 2.0 relaunch and whether user losses stabilize.

HNGE. Hinge Health's valuation reflects the digital health growth premium, the demonstrated category leadership in MSK, and the path-to-profitability story. As a recent IPO, valuation is sensitive to broader digital health sector sentiment and to quarterly progression toward profitability.

Headline figures (approximate, Jul 2026): BMBL shows revenue (q1 2026) ~$212 million, down roughly 14% year over year, net earnings (q1 2026) roughly $53 million, up sharply (about 165%) year over year, adjusted ebitda (q1 2026) approximately $83 million, up around 28% year over year, diluted eps (q1 2026) around $0.34, ahead of consensus estimates; HNGE shows revenue (ttm) ~$400 million (estimated, post-IPO disclosure), operating margin Approaching breakeven; varies by quarter, net income (ttm) Modest GAAP loss; non-GAAP near breakeven, eps (ttm) Near zero.

BMBL and HNGE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BMBL and HNGE exposure against your real portfolio. It is not an investment adviser.